Coagulopathy in two patients with cystic fibrosis treated with ciprofloxacin

被引：2
|
作者：
Moore, Gillian C.
Redfern, Jan
Shiach, Caroline R.
Webb, Kevin
Jones, Andrew M.
机构：
[1] Wythenshawe Hosp, NW Lung Ctr, Manchester Adult Cyst Fibrosis Unit, Manchester M23 9LT, Lancs, England
[2] Wythenshawe Hosp, Dept Haematol, Manchester M23 9LT, Lancs, England
来源：
JOURNAL OF CYSTIC FIBROSIS | 2007年 / 6卷 / 03期
关键词：
cystic fibrosis; ciprofloxacin; coagulopathy; INR; APTT;
D O I：
10.1016/j.jcf.2006.08.002
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
We report two cases of prolonged blood clotting times as demonstrated by a raised international normalised ratio and elevated activated partial thromboplastin time in patients with cystic fibrosis taking ciprofloxacin. The potential mechanisms of a coagulopathy of this picture as an adverse drug reaction with ciprofloxacin are discussed along with the possible clinical consequences for patients with cystic fibrosis. (C) 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：209 / 211
页数：3
相关论文
共 50 条
  • [1] Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis
    Schaad, UB
    Wedgwood, J
    Ruedeberg, A
    Kraemer, R
    Hampel, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (01) : 106 - 111
  • [2] ANAPHYLACTOID REACTIONS TO CIPROFLOXACIN IN CYSTIC-FIBROSIS PATIENTS
    MILLER, MS
    GAIDO, F
    ROURK, MH
    SPOCK, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (02) : 164 - 165
  • [3] THE PK/PD INDEX (CMAX/MIC) FOR CIPROFLOXACIN IN PATIENTS WITH CYSTIC FIBROSIS
    Szalek, Edyta
    Kaminska, Agnieszka
    Gozdzik-Spychalska, Joanna
    Grzeskowiak, Edmund
    Batura-Gabryel, Halina
    ACTA POLONIAE PHARMACEUTICA, 2011, 68 (05): : 777 - 783
  • [4] Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses
    Odoul, F
    Le Guellec, C
    Giraut, C
    de Gialluly, C
    Marchand, S
    Paintaud, G
    Saux, MC
    Rolland, JC
    Autret-Leca, E
    THERAPIE, 2001, 56 (05): : 519 - 524
  • [5] Gene Polymorphism of Biotransformation Enzymes and Ciprofloxacin Pharmacokinetics in Pediatric Patients with Cystic Fibrosis
    Zyryanov, Sergey K.
    Ushkalova, Elena A.
    Kondratyeva, Elena, I
    Butranova, Olga, I
    Kondakova, Yulia A.
    BIOMEDICINES, 2022, 10 (05)
  • [6] Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients
    Cayli, Yagmur Akdag
    Sahin, Selma
    Buttini, Francesca
    Balducci, Anna Giulia
    Montanari, Serena
    Vural, Imran
    Oner, Levent
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2017, 43 (08) : 1378 - 1389
  • [7] Ciprofloxacin/rifampicinCoagulation disorders in patients with cystic fibrosis: 2 case reports
    Reactions Weekly, 2007, 1152 (1) : 9 - 9
  • [8] Ciprofloxacin-induced phototoxicity in an adult cystic fibrosis population
    Tolland, Julia P.
    Murphy, Bryan P.
    Boyle, Julie
    Hall, Valerie
    McKenna, Kevin E.
    Elborn, J. Stuart
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2012, 28 (05) : 258 - 260
  • [9] Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistantPseudomonas aeruginosain patients with cystic fibrosis
    Millar, Beverley Cherie
    McCaughan, John
    Rendall, Jacqueline C.
    Moore, John E.
    CLINICAL RESPIRATORY JOURNAL, 2021, 15 (01) : 116 - 120
  • [10] Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation
    Rubio, TT
    Miles, MV
    Lettieri, JT
    Kuhn, RJ
    Echols, RM
    Church, DA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (01) : 112 - 117
12345